LettersJune 1, 1975Ascorbic Acid-Induced Hemolysis in G-6-PD DeficiencyG. DOUGLAS CAMPBELL JR., B.A., MARTIN H. STEINBERG, M.D., F.A.C.P., JOHN D. BOWER, M.D., F.A.C.P.G. DOUGLAS CAMPBELL JR., B.A.Search for more papers by this author, MARTIN H. STEINBERG, M.D., F.A.C.P.Search for more papers by this author, JOHN D. BOWER, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-82-6-810_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThough the origins of erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency are rooted in human antiquity, the presence of drug-induced hemolysis in individuals subsequently felt to have G-6-PD deficiency was first reported in 1926 and the biochemical lesion responsible for this phenomenon elucidated in 1956 (1). In the United States, hemolysis induced by infection or drugs is the most common clinical manifestation of G-6-PD deficiency (2).Ascorbic acid (vitamin C), an essential vitamin, is commonly used in pharmacologic doses for the prevention of the common cold and to promote the healing of wounds. We report here an individual with G-6-PD deficiency who...